| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.0M | +25.7% |
| Cost of Revenue | $52.0M | +13.5% |
| Gross Profit | $4.0M | +407.4% |
| R&D Expense | $10.6M | -45.8% |
| SG&A Expense | $35.1M | -6.9% |
| Operating Income | -$45.9M | +29.4% |
| Pre-tax Income | -$50.1M | +33.9% |
| Income Tax | $37K | +76.2% |
| Net Income | -$50.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.0M | -5.5% |
| Accounts Receivable | $26.9M | +77.5% |
| Inventory | $36.6M | -3.4% |
| Current Assets | $82.3M | +14.8% |
| Total Assets | $98.3M | +5.0% |
| Current Liabilities | $46.7M | +138.4% |
| Total Liabilities | $64.7M | +33.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.8M | -24.2% |
| Capital Expenditures | $304K | -78.1% |
| Investing Cash Flow | $51.2M | +1.1% |
| Financing Cash Flow | -$3.0M | +92.1% |
| Free Cash Flow | -$49.1M | -20.7% |
| +33.9% |
| EPS (Basic) | -$6.69 | +49.0% |
| EPS (Diluted) | -$6.69 | +49.0% |
| Stockholders' Equity |
| $33.6M |
| -25.6% |